NISHITH.TV
  • Mumbai
  • Silicon Valley
  • Bengaluru
  • Singapore
  • Mumbai BKC
  • New Delhi
  • Munich
  • New York

Locations

  • Mumbai
  • Silicon Valley
  • Bengaluru
  • Singapore
  • Mumbai BKC
  • New Delhi
  • Munich
  • New York
  • Content
  • Home
  • ABOUT US
  • NDA in the Media
  • Areas of Service
  • Research and Articles
  • Opportunities
  • Contact
  • NDACloud
  • Client Access
  • Member Access
  • Events and Calender
  • How we perform
  • Knowledge anywhere, anytime
  • See our recent deals
  • Up to date legal developments
  • Case studies in M&A

Research and Articles

HTMLPDF

  • Research at NDA
  • Research Papers
  • Research Articles
  • Policy Papers
  • NDA Think Tanks
  • NDA Hotline
  • New Ali Gunjan
  • Japan Desk ジャパンデスク

NDA-Hotline


  • Capital Markets Hotline
  • Companies Act Series
  • Climate Change Related Legal Issues
  • Competition Law Hotline
  • Corpsec Hotline
  • Court Corner
  • Cross Examination
  • Deal Destination
  • Debt Funding in India Series
  • Dispute Resolution Hotline
  • Education Sector Hotline
  • FEMA Hotline
  • Financial Service Update
  • Food & Beverages Hotline
  • Funds Hotline
  • Gaming Law Wrap
  • GIFT City Express
  • Green Hotline
  • HR Law Hotline
  • iCe Hotline
  • Insolvency and Bankruptcy Hotline
  • International Trade Hotlines
  • Investment Funds: Monthly Digest
  • IP Hotline
  • IP Lab
  • Legal Update
  • Lit Corner
  • M&A Disputes Series
  • M&A Hotline
  • M&A Interactive
  • Media Hotline
  • New Publication
  • Other Hotline
  • Pharma & Healthcare Update
  • Private Client Wrap
  • Private Debt Hotline
  • Private Equity Corner
  • Real Estate Update
  • Realty Check
  • Regulatory Digest
  • Regulatory Hotline
  • Renewable Corner
  • SEZ Hotline
  • Social Sector Hotline
  • Tax Hotline
  • Technology & Tax Series
  • Technology Law Analysis
  • Telecom Hotline
  • The Startups Series
  • White Collar and Investigations Practice
  • Yes, Governance Matters.
  • Japan Desk ジャパンデスク

IP Hotline

May 8, 2012

Respite for the Pharmaceutical Industry - Controller General publishes a list of International Non-Proprietary Names

In the exercise of powers granted to the Controller General of Patents, Designs and Trademarks ("CG") under the Trade Marks Act, 1999 ("Act"), the CG has published a list of international non-proprietary names ("INN") and has stated that the same cannot be registered as trademark under the Act1.

Background

What are International Non-Proprietary Names (INN)

Often common pharmaceutical substances are referred to by different names, resulting in a confusion regarding the substance used in a particular composition. To resolve this confusion, the World Health Organization ("WHO") has tried to give a separate identity, i.e a unique name to common pharmaceutical substances (such as paracetamol) to ensure safety of the patients. Such INNs are globally recognized names and since they are available in public domain (and are not permitted to be trademarked by anyone), they are called non-proprietary names.

Prohibition of Registration of INNs and words deceptively similar to INNs

In India, registration of INNs and words which are deceptively similar to INNs are prohibited under Section 13 (b) of the Trademark Act, 1999, which states that:

  1. words commonly used and accepted as name of any chemical element/ compound, or
  2. words declared by the WHO and notified by the Registrar of Trade Marks as INNs or names deceptively similar to such name,

shall not be registered under the Act.

Although this section under the TM Act has been in effect since 2003, a list of INNs was not issued until recently. Considering that INNs are used in relation to pharmaceutical substances, recognizing a list of INNs assumed relevance so that same/ similar trademarks cannot be applied for, creating confusion as to the identity of the product. It is with this objective that the CG has issued a list of 8151 names as INNs, which is available here http://www.ipindia.nic.in/list_INN_08February2012.pdf .

With a list of INNs being notified by the CG, any names which are identical or deceptively similar to those on the INN list will not be registered as a pharmaceutical trademark. This will hopefully put an end to a spate of pharmaceutical trademarks litigations where the similarity of the marks becomes the moot question in dispute. This will also ensure that no one manufacturer has an exclusive right over such generic /no-proprietary words or names.


 Minu Ramani, Aarushi Jain & Gowree Gokhale
You can direct your queries or comments to the authors


1 http://www.ipindia.nic.in/OfficeCircular/notification_INN_14February2012.pdf

Mission and Vision


Distinctly Different

What's New


Navigating Governance Challenges: Strengthening Non-Profit Organizations in India
Yes, Governance Matters.: September 30,2023
A step towards fostering transperancy under FCRA
Social Sector Hotline : September 29,2023

Events


Webinars

Impact of The New Indian Data Law on Multinational Companies Operating in India
August 22,2023 - August 22,2023

This event is over. For event material please click here


Seminar

Compliance, Governance, and Leadership
October 06,2023 - October 06,2023

Round Table

Investing In Net Zero
July 22,2022 - July 22,2022

This event is over. For event material please click here

News Roundup


News Articles

Reciprocity requirement for enforcement: A roadblock in ease of doing business?
August 24,2023

Quotes

English, Welsh lawyers have no intention of taking court work away from Indian lawyers: UK Law Society President
September 23,2023

Newsletters


Yes, Governance Matters.

Navigating Governance Challenges: Strengthening Non-Profit Organizations in India
September 30,2023

Social Sector Hotline

A step towards fostering transperancy under FCRA
September 29,2023

Competition Law Hotline

Analysis of the Competition Commission of India (Combinations) Regulations, 2023
September 28,2023

  • Disclaimer
  • Content
  • Feedback
  • Walkthrough
  • Subscribe
Nishith Desai Associates@2016 All rights reserved.